These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27028559)

  • 1. Evaluation of Eu(II) -based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections.
    Ekanger LA; Polin LA; Shen Y; Haacke EM; Allen MJ
    Contrast Media Mol Imaging; 2016 Jul; 11(4):299-303. PubMed ID: 27028559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J; Xu YK; Liu X; Lü GS
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and excretion of lanthanides: comparison between europium salts and complexes.
    Bingham D; Dobrota M
    Biometals; 1994 Apr; 7(2):142-8. PubMed ID: 8148616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the distribution of MRI contrast agents in the livers of small animals by means of complementary microscopies.
    Kahn E; Tessier C; Lizard G; Petiet A; Bernengo JC; Coulaud D; Fourré C; Frouin F; Clément O; Jourdain JR; Delain E; Guiraud-Vitaux F; Colas-Linhart N; Siauve N; Cuenod CA; Frija G; Todd-Pokropek A
    Cytometry A; 2003 Feb; 51(2):97-106. PubMed ID: 12541284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Eu(II)-Containing Cryptate as a Redox Sensor in Magnetic Resonance Imaging of Living Tissue.
    Ekanger LA; Polin LA; Shen Y; Haacke EM; Martin PD; Allen MJ
    Angew Chem Int Ed Engl; 2015 Nov; 54(48):14398-401. PubMed ID: 26428059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
    Harivardhan Reddy L; Sharma RK; Chuttani K; Mishra AK; Murthy RS
    J Control Release; 2005 Jul; 105(3):185-98. PubMed ID: 15921775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity.
    Parac-Vogt TN; Vander Elst L; Kimpe K; Laurent S; Burtéa C; Chen F; Van Deun R; Ni Y; Muller RN; Binnemans K
    Contrast Media Mol Imaging; 2006; 1(6):267-78. PubMed ID: 17191767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroautoradiographic and radiometric studies on the distribution of 3-methylcholanthrene in mice and their fetuses.
    Takahashi G; Yasuhira K
    Cancer Res; 1973 Jan; 33(1):23-8. PubMed ID: 4682320
    [No Abstract]   [Full Text] [Related]  

  • 10. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
    Li Z; Li W; Li X; Pei F; Li Y; Lei H
    Magn Reson Imaging; 2007 Apr; 25(3):412-7. PubMed ID: 17371733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Activity Measurements of Brown Adipose Tissue at 7 T Magnetic Resonance Imaging After Application of Triglyceride-Rich Lipoprotein 59Fe-Superparamagnetic Iron Oxide Nanoparticle: Intravenous Versus Intraperitoneal Approach.
    Jung CS; Heine M; Freund B; Reimer R; Koziolek EJ; Kaul MG; Kording F; Schumacher U; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
    Invest Radiol; 2016 Mar; 51(3):194-202. PubMed ID: 26674208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T1-weighted MR and photoluminescence imaging.
    Jung J; Kim MA; Cho JH; Lee SJ; Yang I; Cho J; Kim SK; Lee C; Park JK
    Biomaterials; 2012 Aug; 33(24):5865-74. PubMed ID: 22617320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose dependence and temporal evolution of the T1 relaxation time and MRI contrast in the rat brain after subcutaneous injection of manganese chloride.
    Shazeeb MS; Sotak CH
    Magn Reson Med; 2012 Dec; 68(6):1955-62. PubMed ID: 22294279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of injected MRI contrast agents in mouse livers studied by confocal and SIMS microscopy.
    Kahn E; Tessier C; Lizard G; Petiet A; Brau F; Clément O; Frouin F; Jourdain JR; Guiraud-Vitaux F; Colas-Linhart N; Siauve N; Cuenod CA; Frija G; Todd-Pokropek A
    Anal Quant Cytol Histol; 2002 Oct; 24(5):295-302. PubMed ID: 12408562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ; Scholz P; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of europium-doped VSOP, customized enhancer solution and improved microscopy fluorescence methodology for unambiguous histological detection.
    de Schellenberger AA; Hauptmann R; Millward JM; Schellenberger E; Kobayashi Y; Taupitz M; Infante-Duarte C; Schnorr J; Wagner S
    J Nanobiotechnology; 2017 Oct; 15(1):71. PubMed ID: 29017510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
    Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN
    J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
    Scholz P; Weinmann HJ; Mützel W; Staks T
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.